Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,619 | 485 | 93.0% |
| Education | $722.36 | 12 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,375 | 146 | $0 (2024) |
| Janssen Biotech, Inc. | $1,563 | 93 | $0 (2024) |
| Lilly USA, LLC | $1,021 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $978.23 | 32 | $0 (2024) |
| GENZYME CORPORATION | $538.52 | 36 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $477.43 | 4 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $381.30 | 12 | $0 (2024) |
| UCB, Inc. | $320.80 | 10 | $0 (2024) |
| LEO Pharma Inc. | $266.06 | 13 | $0 (2024) |
| Blueprint Medicines Corporation | $257.95 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,695 | 142 | ABBVIE INC. ($712.44) |
| 2023 | $1,918 | 90 | AbbVie Inc. ($791.61) |
| 2022 | $1,146 | 67 | Janssen Biotech, Inc. ($287.26) |
| 2021 | $588.76 | 35 | AbbVie Inc. ($194.33) |
| 2020 | $273.70 | 11 | Novartis Pharmaceuticals Corporation ($112.93) |
| 2019 | $1,061 | 41 | Novartis Pharmaceuticals Corporation ($212.06) |
| 2018 | $1,180 | 47 | Novartis Pharmaceuticals Corporation ($257.38) |
| 2017 | $1,479 | 64 | Janssen Biotech, Inc. ($308.82) |
All Payment Transactions
497 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $116.22 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $37.12 | General |
| Category: Immunology | ||||||
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/16/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 5,579 | 18,225 | $1.4M | $364,054 |
| 2022 | 30 | 6,057 | 18,714 | $1.5M | $394,619 |
| 2021 | 33 | 5,179 | 20,706 | $1.2M | $328,972 |
| 2020 | 36 | 5,463 | 17,783 | $1.4M | $360,500 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,365 | 1,691 | $317,046 | $98,269 | 31.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 802 | 1,091 | $237,438 | $45,360 | 19.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 510 | 578 | $161,123 | $42,934 | 26.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 892 | 1,105 | $187,099 | $38,119 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 242 | $66,499 | $20,643 | 31.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 299 | 321 | $65,025 | $19,492 | 30.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 615 | 2,762 | $52,478 | $13,667 | 26.0% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 39 | 9,200 | $28,152 | $11,447 | 40.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 66 | 79 | $29,492 | $9,702 | 32.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 84 | 94 | $28,764 | $9,368 | 32.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 55 | 59 | $22,507 | $7,538 | 33.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 51 | 58 | $20,351 | $6,464 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 160 | 177 | $20,114 | $6,450 | 32.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 42 | 50 | $19,074 | $5,595 | 29.3% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 34 | 319 | $17,239 | $5,400 | 31.3% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 40 | 47 | $12,369 | $3,885 | 31.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 25 | $10,073 | $3,373 | 33.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $13,376 | $3,280 | 24.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $6,198 | $2,233 | 36.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 25 | 25 | $6,987 | $2,010 | 28.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 25 | $7,451 | $2,003 | 26.9% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 15 | 16 | $4,765 | $1,577 | 33.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 37 | $4,625 | $1,355 | 29.3% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 17 | $3,936 | $935.82 | 23.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 24 | 25 | $2,063 | $752.26 | 36.5% |
About Dr. Stephanie Trautman, MD
Dr. Stephanie Trautman, MD is a Dermatology healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275744971.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Trautman, MD has received a total of $10,341 in payments from pharmaceutical and medical device companies, with $2,695 received in 2024. These payments were reported across 497 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,619).
As a Medicare-enrolled provider, Trautman has provided services to 22,278 Medicare beneficiaries, totaling 75,428 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Bend, OR
- Active Since 05/24/2007
- Last Updated 08/04/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1275744971
Products in Payments
- SKYRIZI (Biological) $1,092
- TREMFYA (Drug) $972.83
- COSENTYX (Biological) $884.27
- RINVOQ (Biological) $765.50
- TALTZ (Drug) $659.00
- DUPIXENT (Biological) $654.45
- Tremfya (Drug) $496.08
- STELARA (Biological) $422.49
- Humira (Biological) $364.86
- Otezla (Drug) $241.07
- ILUMYA (Biological) $231.77
- Bimzelx (Biological) $219.77
- Sotyktu (Drug) $209.80
- SPEVIGO (Drug) $181.40
- AYVAKIT (Drug) $169.70
- REMICADE (Biological) $149.41
- VTAMA (Drug) $145.49
- ENSTILAR (Drug) $123.82
- DERMATITIS - DISEASE (Drug) $118.42
- SILIQ (Drug) $116.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bend
Dr. Andrew Jensen, Do, DO
Dermatology — Payments: $10,592
Ms. Kristin Neuhaus, M.d, M.D
Dermatology — Payments: $8,857
Joshua May, M.d, M.D
Dermatology — Payments: $8,786
Fridolin Hoesly, M.d, M.D
Dermatology — Payments: $3,175
Kyle Kaltwasser
Dermatology — Payments: $2,703
Dr. Leslie Carter, Md, MD
Dermatology — Payments: $2,317